ELAN
Elanco Animal Health
Elanco Animal Health historical holders
total: 4
Sound Shore Management Elanco Animal Health transactions over time
- Total transactions:
- 16
- New positions:
- 1
- Sold out:
- 1
- Added:
- 6
- Reduced:
- 8
- Held since:
- 2019 Q1
- Held for:
- 15 quarters
- Latest activity:
- 2022 Q4
Harry Burn has been an institutional investor in Elanco Animal Health (ELAN) since 2019 Q1. According to 2026 Q1 report, Harry Burn doesn't hold any shares. The fund/company first acquired ELAN in 2019 Q1, initially purchasing about 3.60M shares. Since the initial investment, Sound Shore Management has made 15 more transactions in this position.
When did Harry Burn exit their ELAN position?
Harry Burn no longer holds Elanco Animal Health (ELAN). They sold off their entire position in 2022 Q4, closing out an investment that began in 2019 Q1.
When did Harry Burn first invest in ELAN?
Harry Burn first invested in Elanco Animal Health (ELAN) in 2019 Q1 at the reported quarter-end price of $32.07 per share, acquiring 3,604,608 shares in their initial purchase.
What is Harry Burn's average cost basis for ELAN?
Based on historical transaction data, Harry Burn's estimated cost basis for Elanco Animal Health (ELAN) is approximately $29.23 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $29.22
- Weighted AVG sell price:
- $17.89
ELAN transactions history by Sound Shore Management
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$12.41
|
|
-100% (-4,131,801)
|
-2.07%
|
|
2022 Q3
|
2.07%
|
4,131,801
|
$12.41
|
$51,276,000
|
+1.86% (+75,315)
|
+0.04%
|
|
2022 Q2
|
2.92%
|
4,056,486
|
$19.63
|
$79,629,000
|
-5.96% (-257,318)
|
-0.15%
|
|
2022 Q1
|
3.27%
|
4,313,804
|
$26.09
|
$112,547,000
|
+46.53% (+1,369,914)
|
+1.04%
|
|
2021 Q4
|
2.32%
|
2,943,890
|
$28.38
|
$83,548,000
|
+31.64% (+707,593)
|
+0.56%
|
|
2021 Q3
|
2.01%
|
2,236,297
|
$31.89
|
$71,316,000
|
-3.19% (-73,789)
|
-0.07%
|
|
2021 Q2
|
2.23%
|
2,310,086
|
$34.69
|
$80,137,000
|
-0.80% (-18,576)
|
-0.02%
|
|
2021 Q1
|
2.00%
|
2,328,662
|
$29.45
|
$68,579,000
|
-6.82% (-170,318)
|
-0.15%
|
|
2020 Q4
|
2.28%
|
$30.67
|
-15.91% (-472,871)
|
|||
|
2020 Q3
|
2.59%
|
$27.93
|
-27.98% (-1,154,646)
|
|||
|
2020 Q2
|
2.73%
|
$21.45
|
+8.31% (+316,626)
|
|||
|
2020 Q1
|
2.97%
|
$22.39
|
+6.78% (+241,811)
|
|||
|
2019 Q4
|
2.45%
|
$29.45
|
+2.63% (+91,580)
|
|||
|
2019 Q3
|
1.92%
|
$26.59
|
-2.99% (-107,294)
|
|||
|
2019 Q2
|
2.35%
|
$33.80
|
-0.58% (-20,834)
|
|||
|
2019 Q1
|
2.22%
|
$32.07
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.